Am J Health Syst Pharm. 2016 Aug 1;73(15):1144-65. doi: 10.2146/ajhp160215. Epub 2016 Jun 7.
Best practices and guidance are provided for improved electronic detection and alerting of inadvertent supratherapeutic cumulative doses of acetaminophen and other medications with narrow therapeutic ranges in inpatient settings.
Despite the use of medication safety technologies, overdosage and associated sentinel events continue to be serious problems in many inpatient settings. The tools needed to monitor and employ dose alerts, accumulators, and warning systems are available to reduce inadvertent overdose. Required are staff training and the implementation of processes that provide guidance and documentation of the drug reconciliation process from admittance to discharge for safe patient passage through the various transitions of care. Recommendations to achieve optimal patient safety outcomes include the adoption and integration of available technologies with full functionality configured to meet the institution's policies and processes, initial training and retraining of all staff who use these systems, continuing education of the patient care staff on the dosing safety requirements, and assigning a prominent role to the clinical pharmacist in the entire drug-use and reconciliation process.
The key factors contributing to inadvertent overdosage in inpatient settings include a lack of recognition of recommended maximum daily dosages; failure to optimally communicate medication information at transitions of care; failure to optimally implement medication safety technologies, particularly dose accumulator calculation features and associated alerts; and alert fatigue and override.
提供最佳实践和指导,以改进住院环境中对乙酰氨基酚及其他治疗窗窄的药物意外超治疗累积剂量的电子检测和警报。
尽管使用了药物安全技术,但在许多住院环境中,用药过量及相关的警讯事件仍然是严重问题。监测和使用剂量警报、累积器及警示系统所需的工具已具备,可减少意外用药过量。需要进行员工培训,并实施相关流程,为从入院到出院的药物重整过程提供指导和文件记录,以确保患者安全度过各个护理转接环节。实现最佳患者安全结果的建议包括采用并整合具备全部功能且配置为符合机构政策和流程的现有技术,对所有使用这些系统的员工进行初始培训和再培训,对患者护理人员进行用药剂量安全要求的持续教育,并在整个药物使用和重整过程中赋予临床药师重要角色。
导致住院环境中意外用药过量的关键因素包括未认识到推荐的每日最大剂量;在护理转接时未能最佳地传达用药信息;未能最佳地实施药物安全技术,特别是剂量累积器计算功能及相关警报;以及警报疲劳和忽略警报。